Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PREVDUO® safely and effectively. See full prescribing information for PREVDUO®. PREVDUO® (neostigmine methylsulfate and glycopyrrolate) injection, for intravenous use Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
PREVDUO®, a fixed dose combination of cholinesterase inhibitor and antimuscarinic agent, is indicated in patients age two years and above for the reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery, while decreasing the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) associated with cholinesterase inhibition following NMBA reversal administration.
- generic_name
- neostigmine methylsulfate and glycopyrrolate
- product_names
- neostigmine methylsulfate and glycopyrrolate
- ndc
- 42023-269, 42023-269-01, 42023-269-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en